Sinoxa Pharma

Sinoxa Pharma is a biotechnology company based in San Diego, California, dedicated to developing innovative, non-opioid therapies for pain management. The company's primary focus is on addressing the significant unmet need for effective analgesics that lack the addiction potential and central nervous system side effects of traditional opioids. Its lead candidate, SNX-101, is a proprietary small molecule designed to be peripherally restricted, ensuring targeted pain relief while minimizing systemic risks. Founded by Dr. Srinivas Rao, an experienced leader in neuroscience and drug development, Sinoxa leverages advanced medicinal chemistry to create safer alternatives for patients suffering from chronic and acute pain conditions. The company operates within the vibrant San Diego biotech ecosystem, focusing on high-impact solutions to the global opioid crisis.